Prosthetic Joint Infection Market to Observe Impressive Growth by 2032, Evaluates DelveInsight | Key Companies- Joint Purification Systems, ContraFect Corporation, TenNor Therapeutics, and Peptilogics

Delveinsight Business Research LLP
DelveInsight’s “Prosthetic Joint Infection Market Insights, Epidemiology, and Market Forecast 2032” report delivers an in-depth understanding of the disease, historical and forecasted epidemiology as well as the Prosthetic Joint Infection Market Size and Share in the 7MM (i.e. the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).

The Prosthetic Joint Infection market report covers emerging drugs, current treatment practices, market share of the individual therapies, current and forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the market. 

Prosthetic Joint Infection: An Overview

Prosthetic joint infection (PJI) is a chronic difficulty that occurs after joint arthroplasty most commonly in the hip, knee, shoulder, and ankle replacements, which is related to pain. It causes prolonged hospital stay, multiple surgeries, functional breakdown, and even mortality.

Early infections manifest can be detected with clear local and systemic signs of inflammation and are mostly caused by high-virulent pathogens. Early-onset PJI occurs 12–24 months after surgery, is frequently due to hematogenous infection but may also be due to extremely indolent infection initiated at the time of surgery.

Prosthetic Joint Infection Market Key Facts

According to the research study published by Li et al. titled, “Management of Periprosthetic Joint Infection”, With the increment of joint prosthetic replacements, the number of postoperative complications has also increased. The infection rate after hip or shoulder replacement is usually less than 1%, after knee replacement less than 2% and after elbow replacement is between 1.9–10.3%.

The study “Prosthetic joint infection development of an evidence-based diagnostic algorithm” by Mühlhofer et al. suggested that the total number of hip and knee arthroplasties performed in the US is constantly increasing, with an expected increase in total knee arthroplasties (TKAs) of approximately 600% by 2030. The incidence of PJI after primary surgery is 0.2–1.1%; in cases of revision surgery, it can reach 5%.

Prosthetic Joint Infection Market

As per Delveinsight, the US accounts for the highest market share of the overall market size of PJI among the 7MM.

The Prosthetic Joint Infection (PJI) Market is anticipated to increase during the forecast period. The increase in the market of PJI is high due to higher life expectancy, lifestyle changes in elderly populations and more opportunities for mobility in older age.

The market outlook section of the report helps to build a detailed comprehension of the historic, current, and forecasted Prosthetic Joint Infection market size by analyzing the impact of current and emerging therapies in the market. It also provides a detailed assessment of the market drivers & barriers, unmet needs, and emerging technologies.

The report gives a thorough detail of the Prosthetic Joint Infection market trend for each marketed drug and late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action (MoA), competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.

Prosthetic Joint Infection Epidemiology

The epidemiology section covers insights into the historical and current Prosthetic Joint Infection patient pool and forecasted trends for every seven major countries (7MM)  from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.  

Prosthetic Joint Infection Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Prosthetic Joint Infection market or expected to get launched in the market during the study period. The analysis covers Prosthetic Joint Infection market uptake by drugs; patient uptake by therapies; and sales of each drug. 

Report’s Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

The report also covers the Prosthetic Joint Infection Pipeline Development Activities and provides valuable insights about different therapeutic candidates in Phase II, and Phase III stages and the key companies in the market involved in developing targeted therapeutics. It also analyses the recent Development such as collaborations, acquisitions, and mergers, licensing patent details, and other information for emerging therapies.

Get Sample PDF –

Prosthetic Joint Infection Therapeutics Analysis

The Prosthetic Joint Infection (PJI) market dynamics is anticipated to change in the coming years owing to the rise in healthcare spending across the world.

Some of the key companies in the Prosthetic Joint Infection (PJI) Market include:

Joint Purification Systems

ContraFect Corporation

TenNor Therapeutics


And many others. 

Prosthetic Joint Infection (PJI) Therapies covered in the report include:

Vancomycin hydrochloride and tobramycin sulfate

Exebacase (CF-301)



And many more.

Get More Detailed Insights into the Emerging Therapies & Key Companies:-

Table of Content

1. Key Insights

2. Executive Summary 

3. Prosthetic Joint Infection Competitive Intelligence Analysis

4. Prosthetic Joint Infection Market Overview at a Glance

5. Prosthetic Joint Infection Disease Background and Overview

6. Prosthetic Joint Infection Patient Journey

7. Prosthetic Joint Infection Epidemiology and Patient Population

8. Prosthetic Joint Infection Treatment Algorithm, Current Treatment, and Medical Practices

9. Prosthetic Joint Infection Unmet Needs

10. Key Endpoints of Prosthetic Joint Infection Treatment

11. Prosthetic Joint Infection Marketed Products

12. Prosthetic Joint Infection Emerging Therapies

13. Prosthetic Joint Infection Seven Major Market Analysis

14. Attribute Analysis

15. Prosthetic Joint Infection Market Outlook (7 major markets)

16. Prosthetic Joint Infection Access and Reimbursement Overview

17. KOL Views on the Prosthetic Joint Infection Market.

18. Prosthetic Joint Infection Market Drivers

19. Prosthetic Joint Infection Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

*The table of contents is not exhaustive; the final content may vary. 

Request Sample PDF for Prosthetic Joint Infection (PJI) Report –

Other Latest Reports By DelveInsight

West Nile Encephalitis Market

DelveInsight’s “West Nile Encephalitis Market” report delivers an in-depth understanding of the historical and forecasted epidemiology, the West Nile Encephalitis market size, shares, and trends analysis in the 7MM (i.e the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan) as well as the emerging therapies and key companies in the therapeutic domain.

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States